Solventum Corporation

NYQ: SOLV
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Solventum Corporation's price action across multiple timeframes using regression channels and statistical scoring.

Get SOLV Z-Score →

About Solventum Corporation

Healthcare Medical Instruments & Supplies
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

📊 Fundamental Analysis

Solventum Corporation demonstrates exceptional profitability, with a profit margin of 18.7%.

The company recently reported -3.7% revenue growth, which is negative, indicating a recent decline in revenue.

Return on Equity (ROE) is 38.9%, which reflects exceptional capital efficiency.

At a current price of $65.79, SOLV currently trades near the bottom of its 52-week range (13%), indicating potential value or weakness (Range: $62.38 - $88.20).

💰 Valuation Insight

SOLV trades at a 70.4% discount (PE: 7.41), which may represent a value opportunity given the sector average of 25.00. Analysts anticipate some earnings pressure, with a higher forward PE.

🏥 Financial Health

Profit Margin Excellent
🔴 Debt/Equity Elevated
🔴 Revenue Growth Weak
Return on Equity Excellent
Beta (Risk) Low Volatility

Key Financials

Market Cap
$11.41B
Trailing P/E
7.41
Forward P/E
9.34
Beta (5Y)
0.77
52W High
$88.20
52W Low
$62.38
Avg Volume
1.25M
Day High
Day Low
Get SOLV Z-Score on Dashboard 🚀